JPRN-UMIN000002575已完成未知
A Double-Blind, Placebo-Controlled Study With 2-Docosahexaenoyl-3-Phosphatidylserine in Cognitive Disorder - A Double-Blind, Placebo-Controlled Study With 2-Docosahexaenoyl-3-Phosphatidylserine in Cognitive Disorder
Polyene Project, Ltd.0 个研究点目标入组 60 人开始时间: 2009年10月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
There was no statistically significant difference between groups.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 55years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Those aged between 55 and 64 whose scores of MMSE are under 21, those aged between 65 or over whose scores are under 18. 2. Those who, during the last 3 months, have continuously been taking central nervous system agent(s). However, those who have continuously been taking them at low dose levels as sleep-inducers are eligible. 3. Those who, during the last three months, have continuously been taking supplement(s) as follows: fish oils, phosphatidylserine, phosphatidylcholine or any other supplements which affect lipid metabolism. 4. Those suffering from alcoholism, schizophrenia, bipolar disorder or other psychiatric disorders. 5. Those suffering from other serious organic disease such as cancer. 6. Those who are allergic to marine products including cuttlefishes or octopuses. 7. Those who are considered not to be appropriate for the study by the doctor in charge of the present trial.
研究者
相似试验
已完成
不适用
A clinical study to evaluate the safety and efficacy of cognitive enhancing function of of a white ginseng extractDiseases of the nervous systemKCT0004636Seoul National University Hospital76
进行中（未招募）
不适用
A double blind, randomized study to compare influence of niacin/laropiprant on functional and morphological characteristics of arterial wall and parameters of inflammation in subjects with CHD already treated with a statiTo evaluate the influence of 12 weeks of ER niacin/laropiprant therapy on endothelial dependent dilatation of the arterial wall in CHD patients already treated with a statin compared to placebo as well as the influence on serum lipids and the parameters of inflammation (TC, LDL, HDL, Tg, NonLDL C, Lp a, CRP, IL-6, TNF-a, TFPI, PAI-1 antigen and activity, t-PA antigen and activity ) in CHD patients already treated with a statin compared to placebo.EUCTR2009-017622-39-SIClinical Center Ljubljana62
进行中（未招募）
不适用
Randomized Double-blind Study Comparing the Efficacy of Duloxetine with Placebo in Patients with Chronic Low Back PaiEUCTR2009-012713-22-ATMedizinische Universität Wien, Univ. Klinik für Anästhesie, Allg. Intensivmedizin u Schmerztherapie
进行中（未招募）
1 期
A Comparative Double Blind Placebo-Controlled Study of Immunogenicity and Safety of two doses 10 ^5 and 10^7 CFU of SC599 oral vaccine, a Live Attenuated Shigella dysenteriae 1 vaccine strain in Healthy Human Adult Volunteers » - Oral Shigella SC599 vaccine Phase 2a studyEUCTR2004-001915-78-GBInstitut Pasteur111
尚未招募
1 期
Controlled randomized double blind study: Comparison of Dexmedetomidine versus Propofol for Maintenance of Anesthesia during invasive procedures In Pediatric Oncology Patientspediatric oncologyAnaesthesiology - AnaestheticsCancer - Children's - Leukaemia & LymphomaACTRN12613000149763Ahmad ramzy40